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SUMMARY
We have studied five pigs undergoing bilateral
clamping of the renal pedicles, seven pigs
undergoing orthotopic liver transplantation and
three control animals without surgery in order to
examine the roles of the kidney and liver in the
plasma clearance of pipecuronium. An i.v. in-
fusion of pipecuronium was controlled to main-
tain a constant 90-95% twitch depression
throughout the investigation. The right sciatic
nerve was stimulated continuously with supra-
maximal stimuli at 0.1 Hz and the force of the
corresponding evoked isometric muscle con-
traction was recorded continuously. Control pigs
needed an infusion rate of pipecuronium 8-
10.7 fig kg-' min-'. In the renal group, it was
necessary to reduce the infusion rate of pipe-
curonium by about 25% after clamping both
renal vascular pedicles (P < 0.05 compared with
controls); in pigs undergoing liver transplan-
tation, it was necessary to reduce the rate by
approximately 80% after clamping hepatic
vessels (P < 0.05 compared with controls and
from the period after clamping of renal vessels).
After hepatic recirculation, the infusion rate of
pipecuronium was increased progressively to a
rate which corresponded to 50% of baseline
values (P < 0.05 compared with the anhepatic
phase and from controls). Plasma concentrations
of pipecuronium were comparable in the three
animal groups and did not change significantly
during the study. These data suggest that the
liver plays a more important role than the kidney
in the plasma clearance of pipecuronium in pigs.
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Pipecuronium bromide is a new long acting non-
depolarizing steroidal neuromuscular blocking
drug, which has pharmacodynamic and pharmaco-
kinetdc profiles similar to those of pancuronium,
but without cardiovascular side effects [1-3]. In
patients without renal function, plasma clearance
of pipecuronium remains at 60% of normal
values, suggesting that only 40% of an ad-
ministered dose is dependent on the kidneys for
its elimination [4]. There are no data available on
the role of the liver, except for one animal study in
rats indicating minimal hepatic elimination [5].
To evaluate the roles of the kidney and the liver
on the dose requirement of pipecuronium, we
have measured the rate of infusion and the
corresponding plasma concentration of pipe-
curonium necessary to maintain a steady state
neuromuscular block before and after ligature of
the renal vascular pedicles, and with and without
the liver during orthotopic liver transplantation in
pigs.
METHODS
Fifteen pigs (Sus scrofa domesticus) weighing
22-25 kg were included in the study, after ap-
proval of the Ethics Committee on animal research
of our institution. Animals were allocated to three
groups: group A as control group (n = 3), group B
undergoing ligature of both renal vascular
pedicles (n = 5), and group C undergoing ortho-
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topic liver transplantation (« = 7). Animals from
the control group underwent identical monitoring
and anaesthesia, but without surgery.
Procedure
Each animal received azaperone 4 mg kg"1,
ketamine 7.5 mg kg"1 and fentanyl 2 ug kg"1 i.m.
30 min before anaesthesia comprising 2-3 % iso-
flurane in oxygen. The trachea was intubated
without the use of neuromuscular block and
anaesthesia was maintained with 0.5 % isoflurane
in oxygen and fentanyl 4ug kg"1 h"1. Ventilation
was controlled to keep arterial PcOj at 5.0-5.5 kPa,
and body temperature was maintained at 36.0-
37.5 °C with thermoblankets. Normal saline was
infused i.v. through a jugular vein at 10 ml kg"1
h"1. Mean systemic arterial pressure and central
venous pressure were measured using a carotid
arterial cannula and a central venous catheter,
respectively, and calibrated pressure transducers
(1290 A Hewlett-Packard) positioned at the mid-
axillary line, and were recorded on a chart recorder
(Hewlett-Packard, 78172 A). Arterial pH was
maintained at 7.35-7.50 (with sodium bicarbonate,
if necessary). The right posterior leg of the pig
was immobilized and the sciatic nerve was isolated
surgically in the popliteal space. Using a nerve
stimulator (Laubscher PI NS-2B), continuous
supramaximal stimulation of 0.2 ms duration at
0.1 Hz frequency was applied directly to the nerve
branch supplying the tibialis anterior muscle. The
corresponding evoked isometric contraction of the
tibialis anterior muscle was recorded continuously
by a Grass FT-10 force-displacement transducer
on a one-channel recorder (Kipp and Zonen BD
8). After stable anaesthesia had been established
for at least 30 min, a single i.v. bolus injection of
pipecuronium of 150 ug kg"1 was administered,
followed 5 min later by an i.v. infusion of
pipecuronium delivered by an infusion pump
(Vickers Medical, Model SP55) and adjusted
continuously to maintain a constant 90-95 %
twitch depression. The initial bolus dose of
pipecuronium (ED96 = 150 ±20 ug kg"1) was de-
termined by a cumulative dose technique in a
preliminary study in five pigs. Blood samples for
measurement of pipecuronium concentrations
were drawn every 15 min, from 30 min after the
beginning of pipecuronium infusion to the end of
operation.
In animals undergoing bilateral renal exclusion,
both renal vascular pedicles were prepared, and
after a 60-min period of stabilization during which
neuromuscular function was recorded, the
pedicles were ligated and divided. The laparotomy
was closed and the animals were studied during
the following 120 min. In animals undergoing
orthotopic hepatic transplantation with a second
donor liver, the surgical procedure consisted of
three parts. The first phase corresponded to the
preparation of the vessels for insertion of the
cavo-porto-jugular bypass and dissection of hep-
atic ligaments and vessels to allow the hepa-
tectomy. During the anhepatic (second) phase,
splanchnic blood was drained into the internal
jugular vein using an external active non-occlusive
veno-venous bypass (BP 50 Biomedicus,
Minnesota, U.S.A.). The bypass had a priming
volume of 320 ml, flow rate of 1000 ±200 ml
min"1 and ejection pressure of 100-120 mm Hg.
The third phase consisted of the period after
recirculation of the graft during which end-to-end
anastomosis of the hepatic artery and cholecysto-
duodenostomy were performed.
Measurement of plasma concentrations of
pipecuronium
One millilitre of whole blood was collected in a
heparinized tube and centrifuged immediately at
5000 g for 30 s; 500 ul of plasma was transferred
into an Eppendorf tube and frozen quickly to
— 70 °C in acetone and dry ice. Samples were
stored at — 70 °C until analysed. Plasma concen-
trations of pipecuronium were measured by a new
technique using iodine-labelled bengal rose [6].
This technique consists of producing a complex
between pipecuronium and iodine-labelled bengal
rose. By comparison with an appropriate cal-
ibration curve, measurement of radioactivity of
this complex permits measurement of pipecu-
ronium. The use of 1!6I-bengal rose with a specific
activity of 150 uCi mg"1 permitted measurement
of pipecuronium to a detection limit of 5 ng ml"1.
This assay is linear over the range 5-5000 ng ml"1,
with a correlation coefficient of 0.99 in pig plasma.
Inter-assay coefficients of correlation (for 10
assays) were 16.1% at 10 ng ml"1 and 5.4% at
100 ng ml"1 of pipecuronium. Intra-assay co-
efficients of correlation (for 10 assays) were 10.5%
at lOngml"1 and 3.2% at 100 ng ml"1 of
pipecuronium. Metabolites of pipecuronium and
other anaesthetic agents do not interfere with
measurement of pipecuronium concentrations [7].
Statistical analysis
In each animal group, recorded variables over
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time were compared by one-way analysis of
variance for repeated measurements followed by
Bonferroni's multiple comparisons test; com-
parisons between the three animal groups were
made using a one-way analysis of variance fol-
lowed by a Duncan's multiple comparisons test.
For all statistical comparisons, differences were
considered significant if P < 0.05.
RESULTS
Pipecuronium- induced neuromuscular block was
stable at 90-95 % twitch depression in each animal
of the three groups during the entire investigation.
In control animals, a mean infusion rate of
pipecuronium of 8.3 ug kg"1 min"1 (range 8-10.7
ug kg"1 min"1) was necessary to maintain neuro-
muscular block at 90-95 % twitch depression
during the 240-min study period (fig. 1). To
maintain a similar neuromuscular block in pigs
with bilateral renal exclusion, a mean infusion
rate of pipecuronium of 8.9 ug kg"1 min"1 (range
7-11 |ig kg"1 min"1) was necessary before
clamping both renal pedicles (ns at each time
interval compared with control animals). After
exclusion of both kidneys, the infusion rate had to
be reduced significantly within 15 min to mean 6.9
(SEM 0.8) ug kg"1 min"1 (P < 0.05 compared with
the period before clamping of renal vessels), and it
remained at this lower rate for the 2 h to the end
of the study. To maintain block at 90-95 % twitch
depression in pigs undergoing liver transplan-
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FIG. 1. Mean infusion rate of pipecuronium adjusted to main-
tain a stable 90-95% twitch depression in three control
pigs (A)J in seven pigs undergoing orthotopic liver transplan-
tation ( • ) , and in five pigs undergoing bilateral renal ex-
clusion (O)- Data points represent mean (SEM) of values
measured every 15 min. Clamp = clamping of renal and hep-
atic vessels; Unclamp = restoration of hepatic circulation.
P < 0.05: *compared with control; fcompared with pigs with
bilateral renal exclusion.
tation, the mean infusion rate of pipecuronium
was 9.3 ug kg"1 min"1 (range 6-12 ug kg"1 min"1)
during the period before clamping of hepatic
vessels (ns at each interval time compared with
control animals). After clamping of liver vessels,
we observed a rapid increase in the neuromuscular
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FIG. 2. Plasma concentrations of pipecuronium during a 240-min i.v. infusion of pipecuronium adjusted
to maintain a stable 90-95 % twitch depression in control pigs. Data points represent mean (SEM) of three
animals measured every 15 min.
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block (up to 100%), despite reduction in the
infusion rate. In order to restore 90-95 % neuro-
muscular block rapidly, we stopped the infusion
for a short time (10—15 min) and subsequently the
infusion rate of pipecuronium was maintained at
1.2(0.5) and 1.5 (0.7) ug kg"1 min"1 up to
recirculation of the liver (P < 0.05 for each data
point compared with the period before clamping
of hepatic vessels, controls and the period after
clamping of renal vessels) (fig. 1). To maintain a
comparable neuromuscular block after restoration
of the circulation to the liver, the mean infusion
rate of pipecuronium was increased progressively
over 45 min to 4.3 (0.4) |ig kg"1 min"1 and main-
tained at these values during 60 min up to the
end of the study. These infusion rates were
significantly (P < 0.05) greater than those during
the anhepatic phase, but significantly (P < 0.05)
less than those during the period before exclusion
of the liver.
Plasma concentrations of pipecuronium in the
control group remained between 1416 (365) ng
ml"1 (smallest) and 2098 (299) ng ml"1 (greatest)
with a mean value of 1783 ng ml"1 and did not
change significantly during the 240-min study
period (fig. 2).
Before and after bilateral renal exclusion,
plasma concentrations of pipecuronium remained
between 1241 (105) ng ml"1 (smallest) and 1677
(212) ng ml"1 (greatest) with a mean value of 1460
ng ml"1 (ns compared with control group) and did
not change significantly during the entire investi-
gation, despite a 120-min duration of bilateral
renal exclusion (fig. 3).
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FIG. 3. Plasma concentrations of pipecuronium before and
after bilateral renal exclusion (f) in pigs receiving an i.v. in-
fusion of pipecuronium adjusted to maintain a stable 90-95 %
twitch depression. Data points represent mean (SEM) of five
animals measured every 15 min, and were not statistically
different over time (two-way ANOVA).
Plasma concentrations of pipecuronium during
the three different phases of liver transplantation
remained between 1332 (257) ng ml"1 (lowest) and
2513 (620) ng ml"1 (greatest) with a mean value of
1988 ng ml"1 (as compared with control group)
and did not change significantly during the entire
investigation, despite a 90-min duration of liver
exclusion (fig. 4).
Rectal temperature was maintained in the
control group at 38.0 ± 0.1 °C, during the three
phases of liver transplantation (before liver ex-
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FIG. 4. Plasma concentrations of pipecuronium during the three phases of orthotopic liver transplantation
in pigs receiving an i.v. infusion of pipecuronium adjusted to maintain a stable 90-95% twitch
depression. J. = Crossclamp of hepatic artery; f = crossclamp of portal vein; ^restoration of hepatic
circulation. Data points represent mean (SEM) of seven animals measured every 15 min, and were not
statistically different over time (two-way ANOVA).
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TABLE I. Time course, haemodynamic variables, PaCOj, arterial pH, and rectal temperature (mean (SEM)) in the three groups of
animals. MAP = Mean arterial pressure; CVP = central venous pressure. P < 0.05: * compared toith before crossclamping of liver
vessels; -[bettveen control group and the period before crossclamping of liver vessels
Duration (min)
Heart rate (beat min'1)
MAP (ram Hg)
CVP (mm Hg)
Paco, (kPa)
Arterial pH
Rectal temperature (°C)
Control
240
118(6)
69 (2)t
2(1)
4.7(0.13)
7.41 (0.01)
38.0(0.1)
Liver transplantation
Before clamping
liver vessels
128(7)
112(5)
92(3)
2(1)
4.5(0.13)
7.43(0.01)
37.8(0.1)
Anhepatic
phase
95(5)
113(5)
78(3)
2(1)
4.7(0.13)
7.38(0.01)*
37.9(0.1)
After hepatic
recirculation
122(10)
151 (5)*
88(3)
3(1)
4.8(0.13)
7.35(0.01)*
37.6(0.1)
Renal exclusion
Before clamping
renal vessels
90
115(6)
74(6)
3(1)
4.8(0.13)
7.43 (0.01)
37.9(0.1)
After clamping
renal vessels
120
113(7)
72(5)
3(1)
4.7(0.13)
7.41 (0.01)
37.8(0.1)
elusion: 37.8±0.1°C; during cross-clamping:
37.9±0.1°C; after liver recirculation: 37.6
±0.1 °C) and in animals undergoing bilateral
clamping of renal vessels (before kidney ex-
clusion: 37.9±0.1%, after kidney exclusion:
37.8±0.1°C). Arterial pH remained stable in
control animals (7.41 ±0.01) and in animals with
bilateral renal exclusion (before kidney exclusion:
7.43±0.01; after kidney exclusion: 7.41 ±0.01)
during the entire study period. In animals under-
going liver transplantation, arterial pH decreased
significantly (P < 0.05) during the anhepatic
phase compared with the period before clamping
of hepatic vessels (7.43 ±0.01 vs 7.38 ±0.01,
respectively) and remained at values less than
control after restoration of the hepatic circulation
(7.35 ±0.02).
In the control group and in animals with
bilateral renal exclusion, the cardiovascular
variables remained within 20 % of baseline during
the entire investigation (table I). In animals
undergoing liver transplantation, mean systemic
arterial pressure and central venous pressure did
not change significantly during the three phases of
liver transplantation. In contrast, these animals
developed significant tachycardia after restoration
of hepatic circulation (from 112±5tol51±5 beat
min"1) (P < 0.05).
DISCUSSION
The results of the present study demonstrate that
in pigs, bilateral renal exclusion and absence of
the liver produced respectively 25% and 80%
decreases in the dose requirement of pipecu-
ronium necessary to maintain constant neuro-
muscular block without significant change in
plasma concentrations of pipecuronium. This
indicates that the liver plays a more important role
than the kidney in plasma clearance of this agent
in pigs.
To determine plasma concentrations of pipe-
curonium, we used a new method based on the
production of a complex between pipecuronium
and iodine-labelled bengal rose [6]. This assay is
specific for the parent compound and does not
measure metabolites of pipecuronium. It has
detection limits less than those of the colori-
metric assay described earlier [7, 8] and gives
results comparable to those of the recently
published capillary gas chromatographic assay for
quaternary ammonium steroidal neuromuscular
blocking agents [9].
In control animals, administration of a 150-ug
kg"1 bolus and of a 8.3-ug kg"1 min"1 constant rate
i.v. infusion of pipecuronium allowed us to
produce and maintain a stable 90-95% twitch
depression, which was associated with stable
plasma concentrations of pipecuronium during
the entire study. Doses of pipecuronium used in
this study in pigs were twice the dose necessary in
humans [10]. This high requirement for myo-
neural blockers in pigs has been reported for other
drugs, such as atracurium [11], vecuronium and
gallamine [12].
To maintain a similar twitch depression in
animals undergoing ligature of both renal vascular
pedicles, before renal exclusion we needed an
infusion rate of pipecuronium comparable to that
required in control animals. Plasma concentra-
tions of pipecuronium measured before clamping
of renal vessels were also comparable to those
determined in the control group. Similarly, in-
fusion rate and plasma concentrations of pipe-
curonium measured before crossclamping of hep-
atic vessels were comparable to those measured in
784
control animals. These findings suggest that our
control animals may be considered as true con-
trols, although they did not undergo surgery.
Isofiurane anaesthesia (1 MAC) alone does not
modify hepatic blood flow [13], and isoflurane in
a concentration similar to that used in the present
study in association with surgical stress (lap-
arotomy) produces only a small decrease in hepatic
blood flow [14].
Exclusion of both kidneys produced a 25%
reduction in dose requirement of pipecuronium.
Despite significant reduction in infusion rate,
plasma concentration of pipecuronium remained
stable. Our data are comparable to the 34%
reduction in plasma clearance of pipecuronium
observed in patients undergoing cadaver renal
transplantation [4] compared with clearance in
patients with normal renal function. In contrast,
in dogs studied 1 h after bilateral renal exclusion,
an 85 % reduction in plasma clearance of pipecu-
ronium was observed in comparison with control
animals [15]. These differences probably reflect
species variation.
Exclusion of the liver produced an 80%
reduction in dose requirements of pipecuronium
necessary to maintain similar neuromuscular
block as that before clamping of liver vessels
without significant changes in plasma concentra-
tions of this agent. Many factors may explain this
change. We did not evaluate renal function of our
pigs undergoing liver transplantation but urine
output was maintained at values greater than 1 ml
kg"1 h"1 during the entire investigation, and we
found a maximal decrease in dose requirements of
pipecuronium, after bilateral renal exclusion, of
only 25%. Therefore, it is unlikely that changes
in renal function alone could explain this decrease
in dose requirement. Other important factors
affecting pharmacodynamics, such as systemic
haemodynamics, temperature or blood pH, re-
mained within the physiological range during the
period of liver exclusion. Increased receptor
sensitivity and a decrease in volume of distri-
bution of pipecuronium induced by exclusion of
the liver could also be evoked. However, during
the anhepatic phase, we used an external veno-
venous bypass to allow drainage of die splanchnic
circulation which represents an important part of
the total blood volume in pigs, avoiding possible
changes in volume of distribution of pipe-
curonium. In a previous study, we used die same
animal model to investigate atracurium, a neuro-
muscular blocking drug known to be independent
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of the kidneys and liver for its elimination [11].
We have found that plasma concentrations and
infusion rates of atracurium did not change
significantly during the anhepatic phase compared
with the period before clamping of the hepatic
vessels. In contrast, plasma concentrations of its
metabolite laudanosine, known to be metabolized
in die liver, increased significantly after exclusion
of the liver compared widi die period before
clamping of the hepatic vessels. Therefore, it is
unlikely that increased sensitivity of die neuro-
muscular junction during die anhepatic phase
could explain our findings and we conclude diat
diere is significant hepatic uptake of diis neuro-
muscular blocker in animals widi normal liver
function. The importance of die liver was further
confirmed by die fact diat, in all animals, it was
necessary to increase die infusion rate of pipe-
curonium significandy during die first 1 h after
reperfusion of die liver graft. However, dose
requirement of pipecuronium was significantly
less dian diat before crossclamping of hepatic
vessels, probably because of decreased metabolic
function of die hepatic graft immediately after
transplantation [16]. The reperfusion of die liver
graft was followed immediately by a transient
decrease in arterial pH, which could also result
in a larger dose requirement of pipecuronium.
However, die change observed was probably not
related to pH, as changes in die dose requirement
of pipecuronium occurred after correcting die
metabolic acidosis.
In contrast widi our findings, Agoston and
colleagues reported diat, in cats, temporary hep-
atic exclusion did not alter significandy die
intensity and die time-course of die neuromuscu-
lar blocking effects of pipecuronium [17]. How-
ever, diese audiors did not measure plasma
concentrations of pipecuronium before and dur-
ing a brief period of portocaval shunting (10 min).
It is possible dierefore, mat changes in die
pharmacokinetics of pipecuronium induced by
die short exclusion of die liver are not reflected in
neuromuscular effects. There may also be species-
related differences in hepatic uptake and excretion
of pipecuronium, as reported by die same research
group for pigs and cats in hepatic uptake of odier
myoneural blockers [16, 18]. Previous studies
have also suggested diat diere are differences in
hepatic uptake and distribution of neuromuscular
blocking drugs between die cat and humans [19,
20]. As pig and human liver have similar enzyme
systems [21], die pig is probably more rep-
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resentative than the cat for studying the influence
of the liver on the neuromuscular effects of muscle
relax ants.
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